Answers are grounded in this paper and cite their sources.
Background: Sarcopenic obesity (SO) affects up to 40% of older adults with obesity, yet many remain protected despite comparable metabolic burden. The molecular basis for this heterogeneity remains unknown. Methods: We exposed seventy-two 12-month-old female mice to high-fat diet (HFD) or standard diet for 7 months. Multi-Omics Factor Analysis integrated muscle transcriptomics and metabolomics to identify latent factors explaining phenotypic variation. Results: Despite uniform obesity development, aging HFD mice showed marked heterogeneity in muscle outcomes. Factor 3 uniquely distinguished dietary groups and predicted muscle dysfunction independent of adiposity severity. Factor 3 revealed metabolic exhaustion: despite coordinated upregulation of fatty acid oxidation genes (Fabp3, Lpl, Acadl) and oxidative markers, long-chain acylcarnitines accumulated and free L-carnitine depleted, indicating incomplete β-oxidation. Concurrent activation of p53, TNF/NFκB, and oxidative stress pathways indicated comprehensive metabolic decompensation. Plasma acetylcarnitine and pantothenol achieved AUC 0.91 for discriminating sarcopenia phenotypes. Conclusions: Individual susceptibility to sarcopenic obesity reflects differential metabolic exhaustion rather than obesity severity, detectable through circulating biomarkers.
No takes yet. Share an insight, caveat, or question.
LORENZO et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: